115 related articles for article (PubMed ID: 6669987)
1. Hormonal therapy of gynecologic cancers.
Durant JR
Semin Oncol; 1983 Dec; 10(4 Suppl 4):29-33. PubMed ID: 6669987
[TBL] [Abstract][Full Text] [Related]
2. The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.
Geisler HE
Semin Oncol; 1985 Mar; 12(1 Suppl 1):20-2. PubMed ID: 3975647
[TBL] [Abstract][Full Text] [Related]
3. Steroid receptors in endolymphatic stromal myosis.
Baker VV; Walton LA; Fowler WC; Currie JL
Obstet Gynecol; 1984 Mar; 63(3 Suppl):72S-74S. PubMed ID: 6700885
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
5. The role of progestins in the treatment of breast cancer.
Blumenschein GR
Semin Oncol; 1983 Dec; 10(4 Suppl 4):7-10. PubMed ID: 6230722
[TBL] [Abstract][Full Text] [Related]
6. Progestin therapy in lesions of the endometrium.
Wentz WB
Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
Rose PG
Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: a case report.
Vaughn CB; Chapman JL; Herschman BR; Bonczak MJ; Treisman EJ; Groshko GA; Nirenberg PL
Med Pediatr Oncol; 1990; 18(1):68-71. PubMed ID: 2294393
[No Abstract] [Full Text] [Related]
10. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
Rose PG; Reale FR; Longcope C; Hunter RE
Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
[TBL] [Abstract][Full Text] [Related]
12. Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
Ettinger DS; Allegra J; Bertino JR; Bonomi P; Browder H; Byrne P; Carpenter J; Catalano R; Creech R; Dana B
Semin Oncol; 1986 Dec; 13(4 Suppl 4):9-14. PubMed ID: 3026052
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
Gal D; Edman CD; Vellios F; Forney JP
Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
[TBL] [Abstract][Full Text] [Related]
14. Megestrol acetate therapy for advanced breast cancer.
Gregory EJ; Cohen SC; Oines DW; Mims CH
J Clin Oncol; 1985 Feb; 3(2):155-60. PubMed ID: 3838187
[TBL] [Abstract][Full Text] [Related]
15. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
[TBL] [Abstract][Full Text] [Related]
16. Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
Bonte J; Janssens JP; Ide P
Eur J Gynaecol Oncol; 1986; 7(1):45-50. PubMed ID: 2938955
[TBL] [Abstract][Full Text] [Related]
17. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Kauppila A
Acta Obstet Gynecol Scand; 1984; 63(5):441-50. PubMed ID: 6238499
[TBL] [Abstract][Full Text] [Related]
18. Megestrol acetate: first-line therapy for advanced breast cancer.
Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
[TBL] [Abstract][Full Text] [Related]
19. Experience with hormonal therapy in advanced epithelial ovarian cancer.
van der Vange N; Greggi S; Burger CW; Kenemans P; Vermorken JB
Acta Oncol; 1995; 34(6):813-20. PubMed ID: 7576750
[TBL] [Abstract][Full Text] [Related]
20. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
